AR225776A1 - Un procedimiento para la preparacion de acido 9-oxo-11 alfa-hidroxi-15-metanosulfonamido-16-genoxi-cis-5 w-omega-tetranor prostenoico - Google Patents
Un procedimiento para la preparacion de acido 9-oxo-11 alfa-hidroxi-15-metanosulfonamido-16-genoxi-cis-5 w-omega-tetranor prostenoicoInfo
- Publication number
- AR225776A1 AR225776A1 AR282561A AR28256180A AR225776A1 AR 225776 A1 AR225776 A1 AR 225776A1 AR 282561 A AR282561 A AR 282561A AR 28256180 A AR28256180 A AR 28256180A AR 225776 A1 AR225776 A1 AR 225776A1
- Authority
- AR
- Argentina
- Prior art keywords
- methanosulfonamide
- genoxi
- prostenoic
- tetranor
- omega
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/076,520 US4232173A (en) | 1979-09-17 | 1979-09-17 | 15-Sulfonamidoprostaglandin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR225776A1 true AR225776A1 (es) | 1982-04-30 |
Family
ID=22132532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR282561A AR225776A1 (es) | 1979-09-17 | 1980-09-17 | Un procedimiento para la preparacion de acido 9-oxo-11 alfa-hidroxi-15-metanosulfonamido-16-genoxi-cis-5 w-omega-tetranor prostenoico |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4232173A (enExample) |
| EP (1) | EP0025687B1 (enExample) |
| JP (1) | JPS5951938B2 (enExample) |
| KR (1) | KR840000964B1 (enExample) |
| AR (1) | AR225776A1 (enExample) |
| AT (1) | ATE1858T1 (enExample) |
| AU (1) | AU518068B2 (enExample) |
| CA (1) | CA1153368A (enExample) |
| DE (1) | DE3061160D1 (enExample) |
| DK (1) | DK392580A (enExample) |
| ES (1) | ES495101A0 (enExample) |
| FI (1) | FI68615C (enExample) |
| GR (1) | GR70288B (enExample) |
| IE (1) | IE50266B1 (enExample) |
| IL (1) | IL61038A (enExample) |
| PH (1) | PH15098A (enExample) |
| PT (1) | PT71807B (enExample) |
| YU (1) | YU236180A (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61126069A (ja) * | 1984-11-21 | 1986-06-13 | Res Dev Corp Of Japan | プロスタグランジン誘導体 |
| JPS63207015A (ja) * | 1987-02-23 | 1988-08-26 | 株式会社日立製作所 | 遮断器装置 |
| US5387608A (en) * | 1993-08-17 | 1995-02-07 | Allergan, Inc. | Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents |
| US5607415A (en) * | 1994-08-18 | 1997-03-04 | Kimberly-Clark Corporation | Flexible absorbent article |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3835179A (en) * | 1972-07-24 | 1974-09-10 | American Cyanamid Co | Novel 15-substituted prostanoic acids and esters |
| US4033996A (en) * | 1973-04-25 | 1977-07-05 | Merck & Co., Inc. | 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins |
| GB1507211A (en) * | 1975-02-14 | 1978-04-12 | Ono Pharmaceutical Co | Prostaglandin analogues |
-
1979
- 1979-09-17 US US06/076,520 patent/US4232173A/en not_active Expired - Lifetime
-
1980
- 1980-09-09 EP EP80303155A patent/EP0025687B1/en not_active Expired
- 1980-09-09 DE DE8080303155T patent/DE3061160D1/de not_active Expired
- 1980-09-09 AT AT80303155T patent/ATE1858T1/de not_active IP Right Cessation
- 1980-09-15 GR GR62889A patent/GR70288B/el unknown
- 1980-09-15 PT PT71807A patent/PT71807B/pt unknown
- 1980-09-15 YU YU02361/80A patent/YU236180A/xx unknown
- 1980-09-15 IE IE1927/80A patent/IE50266B1/en unknown
- 1980-09-15 CA CA000360249A patent/CA1153368A/en not_active Expired
- 1980-09-15 IL IL61038A patent/IL61038A/xx unknown
- 1980-09-16 KR KR1019800003623A patent/KR840000964B1/ko not_active Expired
- 1980-09-16 AU AU62436/80A patent/AU518068B2/en not_active Ceased
- 1980-09-16 PH PH24591A patent/PH15098A/en unknown
- 1980-09-16 ES ES495101A patent/ES495101A0/es active Granted
- 1980-09-16 DK DK392580A patent/DK392580A/da not_active Application Discontinuation
- 1980-09-16 FI FI802904A patent/FI68615C/fi not_active IP Right Cessation
- 1980-09-16 JP JP55128465A patent/JPS5951938B2/ja not_active Expired
- 1980-09-17 AR AR282561A patent/AR225776A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| IE50266B1 (en) | 1986-03-19 |
| PH15098A (en) | 1982-08-10 |
| ATE1858T1 (de) | 1982-12-15 |
| AU518068B2 (en) | 1981-09-10 |
| DE3061160D1 (en) | 1982-12-30 |
| KR830003415A (ko) | 1983-06-20 |
| IL61038A0 (en) | 1980-11-30 |
| IE801927L (en) | 1981-03-17 |
| FI802904A7 (fi) | 1981-03-18 |
| EP0025687A1 (en) | 1981-03-25 |
| JPS5951938B2 (ja) | 1984-12-17 |
| ES8106489A1 (es) | 1981-08-16 |
| CA1153368A (en) | 1983-09-06 |
| GR70288B (enExample) | 1982-09-03 |
| US4232173A (en) | 1980-11-04 |
| ES495101A0 (es) | 1981-08-16 |
| AU6243680A (en) | 1981-03-26 |
| YU236180A (en) | 1983-01-21 |
| PT71807B (en) | 1981-07-02 |
| KR840000964B1 (ko) | 1984-07-02 |
| EP0025687B1 (en) | 1982-11-24 |
| DK392580A (da) | 1981-03-18 |
| IL61038A (en) | 1983-12-30 |
| JPS5651448A (en) | 1981-05-09 |
| FI68615B (fi) | 1985-06-28 |
| PT71807A (en) | 1980-10-01 |
| FI68615C (fi) | 1985-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES494431A0 (es) | Un procedimiento para la preparacion de acido clavulanico | |
| AR227164A1 (es) | Procedimiento para la preparacion de un acido penicilanico 6-beta sustituido | |
| MX6174E (es) | Procedimiento para la preparacion de(4-trifluorometil)-anilida de acido 5-metil-isoxazol-4-carboxilico | |
| ES496705A0 (es) | Un procedimiento para la preparacion de acido griseolico | |
| ES495977A0 (es) | Un procedimiento para la preparacion de derivados acidos penem-carboxilicos | |
| ES487833A0 (es) | Procedimiento para la produccion de un preparado farmaceuti-co | |
| ES499856A0 (es) | Un procedimiento para la preparacion de derivados del acido 7-oxo-1-azabiciclo (3-2-0) hept-2-en-2-carboxilico | |
| ES505679A0 (es) | Un procedimiento para la preparacion de derivados de acido carbamico | |
| ES499035A0 (es) | Un procedimiento para la preparacion de derivados de acido trans-(4-oxo-4h-quinazolin-3-il)-2-propenoico | |
| AR225363A1 (es) | Procedimiento para la preparacion de acido alfa-hidroxi-gamma-metilmercaptobutirico | |
| ES494230A0 (es) | Un procedimiento para la preparacion de amidas del acido po-liprenilcarboxilico | |
| ES492989A0 (es) | Procedimiento para la obtencion de compuestos de acido ami- notiazolacetamido-3-cefem-4-carboxilico | |
| ES500322A0 (es) | Procedimiento para la preparacion de un acido bencenocarbo- xilico | |
| ES489707A0 (es) | Un procedimiento para la purificacion de acido fosforico | |
| ES493506A0 (es) | Un procedimiento para la preparacion de desacetil-cefalospo-rina c | |
| MX5006E (es) | Procedimiento para la preparacion de acido ciclohexancarboxilico | |
| ES490729A0 (es) | Procedimiento para la preparacion de nuevas imidas de acido ciclobutandicarboxilico | |
| ES486465A0 (es) | Un procedimiento para la preparacion de derivados del acido oxisustituido-ciclohexilacetico | |
| AR225776A1 (es) | Un procedimiento para la preparacion de acido 9-oxo-11 alfa-hidroxi-15-metanosulfonamido-16-genoxi-cis-5 w-omega-tetranor prostenoico | |
| ES489119A0 (es) | Un procedimiento para la preparacion de acido 6-cloro-alfa- metil-carbazol-2-acetico | |
| ES489924A0 (es) | Un procedimiento para preparar derivados de acido imidazol- dicarboxilico | |
| ES488136A0 (es) | Un procedimiento para la preparacion de derivados del acido monico | |
| ES491601A0 (es) | Procedimiento para la preparacion de derivados de acido n-acil-amino | |
| MX5206E (es) | Procedimiento para la preparacion de fenoxi-alfa-vinil-bencil-esteres de acido ciclopropancarboxilico | |
| AR223209A1 (es) | Procedimiento para la preparacion de acido metacrilico |